Cyclosporin A-loaded poly(d,l-lactide) nanoparticles: a promising tool for treating alopecia

Nanomedicine (Lond). 2020 Jun;15(15):1459-1469. doi: 10.2217/nnm-2020-0089. Epub 2020 Jun 17.

Abstract

Background: Alopecia treatments are scarce and lack efficacy. Cyclosporin A (CsA) has hair growth-inducing properties but its poor cutaneous absorption undermines its use in topical treatments. Aim: Development of a new potential topical treatment of alopecia with CsA. Materials & methods: CsA-loaded poly(d,l-lactide) (PLA) nanoparticles were obtained and characterized. Skin permeation was evaluated in ex vivo porcine skin. Results: Nanoparticles with good physicochemical stability increased CsA skin permeation/hair follicles accumulation, compared with a noncolloidal formulation. CsA biocompatibility in NCTC2455 keratinocytes (reference skin cell line) was clearly improved when encapsulated in PLA nanoparticles. Conclusion: This work fosters further in vivo investigation of CsA-loaded PLA nanoparticles as a promising new strategy to treat alopecia, a very traumatic, possibly autoimmune, disease.

Keywords: PLA nanoparticles; alopecia; cyclosporin a; hair follicle targeting; hair loss; immunosuppressant; inflammatory skin conditions; skin permeation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Alopecia* / drug therapy
  • Animals
  • Cyclosporine*
  • Drug Carriers
  • Nanoparticles*
  • Polyesters
  • Swine

Substances

  • Drug Carriers
  • Polyesters
  • poly(lactide)
  • Cyclosporine